“Real-World Experience of Upadacitinib Dosing Reduction in Patients With Moderate Atopic Dermatitis: A Case Series Study in Taiwan”. 2024. Dermatology Practical & Conceptual 14 (3): e2024186. https://doi.org/10.5826/dpc.1403a186.